Immunosuppressant drugs and bone disease: A clinician's perspective

Journal of Clinical Densitometry

Volumn 1, Issue 4, 1998, Pages 317-321

  Epstein, Sol ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Bone densitometry; Bone disease; Cyclosporine; Glucocorticoids; Immunosuppression; Posttransplantation

Indexed keywords

EID: 0039449807     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1385/JCD:1:4:317     Document Type: Article

References (18)

1. Reid IR. 1997 Glucocorticoid osteoporosis mechanism and management. Eur J Endocrinol 137:209-217.
2. Canalis E. 1996 Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid induced osteoporosis. J Clin Endocrinol Metab 81:3441-3447.
3. Pearce G, Tabensky A, Delmas PD, Gordon Baker HW, Seeman E. 1998 Corticosteroid-induced bone loss in men. J Clin Endocrinol Metab 83:801-806.
4. Lukert B, Raisz L. 1990 Glucocorticoid induced osteoporosis. Pathogenesis and management. Ann Intern Med 112:352-364.
5. Packe GE, Robb O, Robins SD, Reid DM, Douglas JG. 1996 Bone density in asthmatic patients taking inhaled corticosteroids: comparison of budesonide and beclamethasone dipropronate 1996. J. Royal Coll. Physicians Lond 30:128-132.
6. Epstein S. 1996 Post transplantation bone disease. The role of immunosuppressive agents on the skeleton. J Bone Miner Res 11:1-7.
7. Epstein S, Shane E. 1996 Transplantation osteoporosis. In: Osteoporosis. Marcus R, Feldmann D, Kelsey J, eds. Academic, New York, 947-957.
8. Nisbeth U, Lindh E, Ejunghall S. 1994 Fracture frequency after kidney transplantation. Transplant Proc 26, 1764.
9. Meys E, Fontangnes E, Fournade N, et al. 1996 Bone loss after orthoptic liver transplantation. Am J. Med 97:445-450.
10. Sambrook P, Birmingham J, Kelly P et al. 1993 Prevention of corticosteroids, osteoporosis - a comparison of calcium, calcitrol, and calcitonin N Engl J Med 328:1747-1752.
11. Lukert B, Kream BE. 1996 Clinical and basic aspects of glucocorticoid action in bone. In: Principles of Bone Biology. Bilezikian JP, Raisz LG, Rodan GA, eds. Academy New York, 533-548.
12. Adachi JD, Beusen WG, Brown J, et al. 1997. Intermittent etidronate therapy to prevent corticosteroid induced bone loss. N Engl J Med 337:382-387.
13. Saag KG, Emkey R, Schnitzer JJ, et al. 1998 Alendronate for the prevention and treatment of glucocorticoid induced osteoporosis. N Engl J Med 339:292-299.
14. Valero MA, Loinaz C, Larrodera L, et al. 1995 Calcitonin and bisphosphonate treatment and bone loss after liver transplantation. Calcif Tiss Int 57:15-19.
15. Shane E, Thys-Jacobs S, Papadoulos A, et al. 1996 Antiresorptive therapy prevents bone loss after cardiac transplantation. J Bone Miner Res 11:635 (abstract).
16. Montemurro L, Schiraldi G, Fraioli P, et al. 1991 Prevention of corticosteroid induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif Tiss Int 49:71-76.
17. Meys E, Terreaux Duvert P, Beaume-Six T, et al. 1993 Effects of calcium, calderol, and monofluorophosphate on lumbar bone mass and parathyroid function in patients after cardiac transplantation. Osteoporosis Int 3:329-332.
18. Joffe I, Katz I, Jacobs T, et al. 1992 17 Beta estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin A. Endocrinology 130:578-586.